Status: Recruiting
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
The goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reproductive Technology (ART) cycle in in women with a diagnosis of infertility.
Participants needed: 659
Trial details
Phase: Phase 3Age: 18-42Biological sex: FemaleType: InterventionalSponsor: Granata Bio CorporationUpdated: Apr 27, 2026Locations: 16
Eligibility criteria
Pre-menopausal women aged 18-42 years old at the time of consent. [+17]
Persistent (for >1 cycle), clinically relevant (per PI discretion) ovarian cysti... [+37]